ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,502Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 917

$644K Total Retail Price of All Prescriptions

Rank: 58 out of 917

615 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 615 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 615 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,762 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 516 435 1 1
SIMVASTATIN 513 437 2 2
OMEPRAZOLE 372 311 3 4
HYDROCODONE-ACETAMINOPHEN 352 256 S3 4 6
AMLODIPINE BESYLATE 331 318 5 5
LEVOTHYROXINE SODIUM 313 275 6 3
METFORMIN HCL 250 201 7 8
FUROSEMIDE 232 213 8 7
METOPROLOL TARTRATE 197 181 9 11
ATENOLOL 195 174 10 12
HYDROCHLOROTHIAZIDE 176 151 11 9
LOVASTATIN 164 138 12 19
GABAPENTIN 146 100 13 17
WARFARIN SODIUM 142 132 14 10
CITALOPRAM HBR 137 128 15 15
ALENDRONATE SODIUM 129 121 16 23
TAMSULOSIN HCL 126 109 17 25
LANTUS 125 125 18 37
ATORVASTATIN CALCIUM 122 121 19 14
METOPROLOL SUCCINATE 110 105 20 18
FLUOXETINE HCL 95 84 21 38
ALLOPURINOL 95 88 21 31
TRAZODONE HCL 92 59 23 22
PROAIR HFA 90 75 24 35
NEXIUM 88 88 25 60
PANTOPRAZOLE SODIUM 87 80 26 44
ENDOCET 86 57 S2 27 210
DIGOXIN 83 78 28 41
AZITHROMYCIN 83 76 28 61
ZETIA 81 70 30 93
GLIMEPIRIDE 79 68 31 54
GLYBURIDE 78 66 R 32 71
CARVEDILOL 77 74 33 33
PREDNISONE 74 70 34 34
POLYETHYLENE GLYCOL 3350 74 71 34 66
ADVAIR DISKUS 73 70 36 47
LOSARTAN POTASSIUM 72 70 37 13
ZOLPIDEM TARTRATE 71 56 38 21
SERTRALINE HCL 67 47 39 24
CYCLOBENZAPRINE HCL 67 44 R 39 65
POTASSIUM CHLORIDE 66 63 41 16
OXYCODONE-ACETAMINOPHEN 66 31 S2 41 46
CLOPIDOGREL 63 55 43 50
PAROXETINE HCL 60 23 44 57
RANITIDINE HCL 60 44 44 29
PRAVASTATIN SODIUM 59 52 46 20
RISPERIDONE 59 34 46 51
METHOCARBAMOL 58 33 R 48 87
SPIRONOLACTONE 57 50 49 55
DONEPEZIL HCL 52 51 50 32
DIOVAN 51 46 51 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.